Literature DB >> 25660927

Hyponatremia in acute decompensated heart failure: depletion versus dilution.

Frederik H Verbrugge1, Paul Steels2, Lars Grieten3, Petra Nijst1, W H Wilson Tang4, Wilfried Mullens5.   

Abstract

Hyponatremia frequently poses a therapeutic challenge in acute decompensated heart failure (ADHF). Treating physicians should differentiate between depletional versus dilutional hyponatremia. The former is caused by diuretic agents, which enhance sodium excretion, often with concomitant potassium/magnesium losses. This can be treated with isotonic saline, whereas potassium/magnesium administration may be helpful if plasma concentrations are low. In contrast, as impaired water excretion, rather than sodium deficiency, is the culprit in dilutional hyponatremia, isotonic saline administration may further depress the serum sodium concentration. Because free water excretion is achieved by continuous sodium reabsorption in distal nephron segments with low water permeability, diuretic agents that impair this mechanism (e.g., thiazide-type diuretic agents and mineralocorticoid receptor antagonists) should be avoided, and proximally acting agents (e.g., acetazolamide and loop diuretic agents) are preferred. Vasopressin antagonists, which promote low water permeability in the collecting ducts and, hence, free water excretion, remain under investigation for dilutional hyponatremia in ADHF.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arginine vasopressin; distal; diuretics; kidney tubules; physiopathology; sodium

Mesh:

Substances:

Year:  2015        PMID: 25660927     DOI: 10.1016/j.jacc.2014.12.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  29 in total

1.  Management of Cardio-Renal Syndrome and Diuretic Resistance.

Authors:  Frederik H Verbrugge; Wilfried Mullens; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

Review 2.  Pharmacologic Approaches to Electrolyte Abnormalities in Heart Failure.

Authors:  Justin L Grodin
Journal:  Curr Heart Fail Rep       Date:  2016-08

Review 3.  Diuretic Therapy in Heart Failure - Current Approaches.

Authors:  Gavino Casu; Pierluigi Merella
Journal:  Eur Cardiol       Date:  2015-07

4.  Serial sodium values and adverse outcomes in heart failure with preserved ejection fraction.

Authors:  Tasnim F Imran; Katherine E Kurgansky; Yash R Patel; Ariela R Orkaby; Robert R McLean; Yuk-Lam Ho; Kelly Cho; J Michael Gaziano; Luc Djousse; David R Gagnon; Jacob Joseph
Journal:  Int J Cardiol       Date:  2019-03-22       Impact factor: 4.164

Review 5.  SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

Authors:  Frederik H Verbrugge; Pieter Martens; Wilfried Mullens
Journal:  Curr Heart Fail Rep       Date:  2017-08

Review 6.  Current Approach to Decongestive Therapy in Acute Heart Failure.

Authors:  Pieter Martens; Petra Nijst; Wilfried Mullens
Journal:  Curr Heart Fail Rep       Date:  2015-12

Review 7.  The Basic Metabolic Profile in Heart Failure-Marker and Modifier.

Authors:  Ahmed Elfar; Kamalanathan K Sambandam
Journal:  Curr Heart Fail Rep       Date:  2017-08

8.  Prognostic importance of sodium level trajectory in acute heart failure.

Authors:  Yuya Matsue; Kenji Yoshioka; Makoto Suzuki; Sho Torii; Satoshi Yamaguchi; Seiji Fukamizu; Yuichi Ono; Hiroyuki Fujii; Takeshi Kitai; Toshihiko Nishioka; Kaoru Sugi; Yuko Onishi; Makoto Noda; Nobuyuki Kagiyama; Yasuhiro Satoh; Kazuki Yoshida; Steven R Goldsmith
Journal:  Heart Vessels       Date:  2017-07-11       Impact factor: 2.037

9.  Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function.

Authors:  Takeshi Kitai; Justin L Grodin; Yong-Hyun Kim; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2017-02       Impact factor: 8.790

10.  Importance of Abnormal Chloride Homeostasis in Stable Chronic Heart Failure.

Authors:  Justin L Grodin; Frederik H Verbrugge; Stephen G Ellis; Wilfried Mullens; Jeffrey M Testani; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.